Dried blood spots perform well in viral load monitoring of patients who receive antiretroviral treatment in rural Tanzania

Clinical Infectious Diseases

Volumn 49, Issue 6, 2009, Pages 976-981

  Johannessen, Asgeir ^a,b   Garrido, Carolina ^f   Zahonero, Natalia ^f   Sandvik, Leiv ^b   Naman, Ezra ^g   Kivuyo, Sokoine L ^h   Kasubi, Mabula J ⁱ   Gundersen, Svein G ^c,d   Bruun, Johan N ^a,e   De Mendoza, Carmen ^f  

^a Ulleval Department of Infectious Diseases   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c S O Rlandet Hospital HF   (Norway)

^d UNIVERSITY OF AGDER   (Norway)

^e UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^f HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^g HAYDOM LUTHERAN HOSPITAL   (Tanzania)

^h NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (Tanzania)

ⁱ MUHIMBILI NATIONAL HOSPITAL   (Tanzania)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD SAMPLING; BLOOD STORAGE; CHILD; CONTROLLED STUDY; DRIED BLOOD SPOT; DRUG TREATMENT FAILURE; FEMALE; GOLD STANDARD PLASMA ASSAY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERMETHOD COMPARISON; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PRESCHOOL CHILD; PRIORITY JOURNAL; ROOM TEMPERATURE; RURAL AREA; TANZANIA; VIREMIA; VIRUS LOAD;

ADOLESCENT; ADULT; AGED; ANTI-RETROVIRAL AGENTS; BLOOD; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DEVELOPING COUNTRIES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; PLASMA; REAGENT KITS, DIAGNOSTIC; RURAL POPULATION; SENSITIVITY AND SPECIFICITY; SPECIMEN HANDLING; TANZANIA; VIRAL LOAD; YOUNG ADULT;

EID: 70049092748     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/605502     Document Type: Article

References (30)

1. Joint United Nations Programme on HIV/AIDS (UNAIDS). Report on the global AIDS epidemic 2008. Geneva: UNAIDS, 2008.
2. Mills EJ, Nachega JB, Buchan I, et al. Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. JAMA 2006;296:679-690 (Pubitemid 44200639)
3. Ivers LC, Kendrick D, Doucette K. Efficacy of antiretroviral therapy programs in resource-poor settings: a meta-analysis of the published literature. Clin Infect Dis 2005;41:217-224 (Pubitemid 40962502)
4. Hammer SM, Eron JJ Jr, Reiss P, et al. Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel. JAMA 2008;300:555-570
5. European AIDS Clinical Society (EACS). Guidelines for the clinical management and treatment of HIV infected adults in Europe. Paris: EACS, 2008.
6. World Health Organization (WHO). Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach. 2006 revision. Geneva: WHO, 2006.
7. Mee P, Fielding KL, Charalambous S, Churchyard GJ, Grant AD. Evaluation of the WHO criteria for antiretroviral treatment failure among adults in South Africa. AIDS 2008;22:1971-1977
8. Chaiwarith R, Wachirakaphan C, Kotarathititum W, Praparatanaphan J, Sirisanthana T, Supparatpinyo K. Sensitivity and specificity of using CD4+ measurement and clinical evaluation to determine antiretroviral treatment failure in Thailand. Int J Infect Dis 2007; 11:413-416 (Pubitemid 47239450)
9. Cozzi-Lepri A, Phillips AN, Ruiz L, et al. Evolution of drug resistance in HIV-infected patients remaining on a virologically failing combination antiretroviral therapy regimen. AIDS 2007;21:721-732 (Pubitemid 46568629)
10. Mei JV, Alexander JR, Adam BW, Hannon WH. Use of filter paper for the collection and analysis of human whole blood specimens. J Nutr 2001;131:1631S-6S.
11. Brambilla D, Jennings C, Aldrovandi G, et al. Multicenter evaluation of use of dried blood and plasma spot specimens in quantitative assays for human immunodeficiency virus RNA: measurement, precision, and RNA stability. J Clin Microbiol 2003;41:1888-1893 (Pubitemid 36576508)
12. Fiscus SA, Brambilla D, Grosso L, Schock J, Cronin M. Quantitation of human immunodeficiency virus type 1 RNA in plasma by using blood dried on filter paper. J Clin Microbiol 1998; 36:258-260 (Pubitemid 28047472)
13. O'Shea S, Mullen J, Corbett K, Chrystie I, Newell ML, Banatvala JE. Use of dried whole blood spots for quantification of HIV-1 RNA. AIDS 1999;13:630-631 (Pubitemid 29286736)
14. Garrido C, Zahonero N, Corral A, Arredondo M, Soriano V, de Mendoza C. Correlation between HIV-1 RNA measurements in dried blood spots (DBS) and plasma using Nuclisens EasyQ HIV-1 and Abbott Real Time HIV viral load tests. J Clin Microbiol 2009;47:1031-1036
15. Marconi A, Balestrieri M, Comastri G, et al. Evaluation of the Abbott Real-Time HIV-1 quantitative assay with dried blood spot specimens. Clin Microbiol Infect 2009; 15:93-97
16. Johannessen A, Naman E, Ngowi BJ, et al. Predictors of mortality in HIV-infected patients starting antiretroviral therapy in a rural hospital in Tanzania. BMC Infect Dis 2008; 8:52. (Pubitemid 351619259)
17. Boom R, Sol CJ, Salimans MM., Jansen CL, Wertheim-van Dillen PM, van der Noordaa J. Rapid and simple method for purification of nucleic acids. J Clin Microbiol 1990;28:495-503. (Pubitemid 20078123)
18. Bruisten S, van Gemen B, Koppelman M, et al. Detection of HIV-1 distribution in different blood fractions by two nucleic acid amplification assays. AIDS Res Hum Retroviruses 1993;9:259-265 (Pubitemid 23108521)
19. van Gemen B, Wiel P, van Beuningen R, et al. The one-tube quantitative HIV-1 RNA NASBA: precision, accuracy, and application. PCR Methods Appl 1995;4:S177-84.
20. Compton J. Nucleic acid sequence-based amplification. Nature 1991; 350:91-92
21. de Mendoza C, Koppelman M, Montes B, et al. Multicenter evaluation of the NucliSens EasyQ HIV-1 v1.1 assay for the quantitative detection of HIV-1 RNA in plasma. J Virol Methods 2005; 127:54-59 (Pubitemid 40704638)
22. Whatman 903 protein saver cards. Available at: http://www.whatman .com/903ProteinSaverCards.aspx. Accessed 6 May 2009.
23. Ngowi BJ, Mfinanga SG, Bruun JN, Morkve O. Immunohaematological reference values in human immunodeficiency virus-negative adolescent and adults in rural northern Tanzania. BMC Infect Dis 2009; 9:1.
24. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1:307-310 (Pubitemid 16134762)
25. Ferradini L, Jeannin A, Pinoges L, et al. Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment. Lancet 2006;367:1335-1412
26. Novitsky V, Wester CW, Degruttola V, et al. The reverse transcriptase 67N 70R 215Y genotype is the predominant TAM pathway associated with virologic failure among HIV type 1C-infected adults treated with ZDV/ddI-containing HAART in southern Africa. AIDS Res Hum Retroviruses 2007; 23:868-878 (Pubitemid 47267493)
27. Waters L, Kambugu A, Tibenderana H, et al. Evaluation of filter paper transfer of whole-blood and plasma samples for quantifying HIV RNA in subjects on antiretroviral therapy in Uganda. J Acquir Immune Defic Syndr 2007;46:590-593 (Pubitemid 350191052)
28. Kane CT, Ndiaye HD, Diallo S, et al. Quantitation of HIV-1 RNA in dried blood spots by the real-time NucliSENS EasyQ HIV-1 assay in Senegal. J Virol Methods 2008; 148:291-295
29. Hirsch MS, Gunthard HF, Schapiro JM, et al. Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel. Clin Infect. Dis 2008;47:266-285
30. Leelawiwat W, Young NL, Chaowanachan T, et al. Dried blood spots for the diagnosis and quantitation of HIV-1: Stability studies and evaluation of sensitivity and specificity for the diagnosis of infant HIV-1 infection in Thailand. J Virol Methods 2009; 155:109-117